Follow
Antigen-specific T cells
T cells, a type of CD8 T cells (also called cytotoxic T lymphocyte) that are activated against a specific antigen. CD8 T cells identify and eliminate foreign cells, such as cancer cells or virus-infected cells. Antigen specific T cells are capable of identifying a specific antigen that is specific to the invading cells.
What's Popular in Antigen-specific T cells
-
MAY 19, 2025Cell & Molecular Biology
Pancreatic cancer is deadly; only about 10% of patents live over five years after they are diagnosed. Patients are typic ...Written By: Carmen LeitchMAR 04, 2024Cell & Molecular Biology
With astonishing advances in molecular biology, cell and gene therapies represent a new class of pharmaceuticals availab ...Sponsored By: Single Use SupportFEB 29, 2024Immunology
Jennifer Doudna and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in g ...Written By: Brian G. MorrealeFEB 27, 2024Drug Discovery & Development
Published by Beata Boczkowska, Ph.D. The potential for personalized cancer treatment is fueling the need to i ...Sponsored By: MBL International CorporationFEB 22, 2024Immunology
The US Food and Drug Administration (FDA) recently approved a tumor-infiltrating lymphocyte (TIL) therapy referred to as ...Written By: Brian G. Morreale
MAY 19, 2025
Cell & Molecular Biology
Pancreatic cancer is deadly; only about 10% of patents live over five years after they are diagnosed. Patients are typic
...
Written By:
Carmen Leitch
MAR 04, 2024
Cell & Molecular Biology
With astonishing advances in molecular biology, cell and gene therapies represent a new class of pharmaceuticals availab
...
Sponsored By:
Single Use Support
FEB 29, 2024
Immunology
Jennifer Doudna and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in g
...
Written By:
Brian G. Morreale
FEB 27, 2024
Drug Discovery & Development
Published by Beata Boczkowska, Ph.D. The potential for personalized cancer treatment is fueling the need to i
...
Sponsored By:
MBL International Corporation
FEB 22, 2024
Immunology
The US Food and Drug Administration (FDA) recently approved a tumor-infiltrating lymphocyte (TIL) therapy referred to as
...
Written By:
Brian G. Morreale
FEB 15, 2024
Immunology
There are various ways to treat cancer. The gold standard has been chemotherapy for over 50-years. However, treatment wi
...
Written By:
Brian G. Morreale
FEB 08, 2024
Immunology
Summary: Engineered immune cells, known as T cells, were found to eliminate anti-immune cells connected to age-associate
...
Written By:
Brian G. Morreale
FEB 08, 2024
Microbiology
Climate change is raising temperatures around the world, and mosquitoes are on the move. As their territories expand, th
...
Written By:
Carmen Leitch
JAN 22, 2024
Clinical & Molecular DX
Guillain-Barre syndrome (GBS) is an inflammatory disease that affects nerves. It is thought to be an autoimmune disorder
...
Written By:
Carmen Leitch
-
MAR 28, 2024 | 8:00 AM
B cell responses within pancreatic ductal adenocarcinoma (PDAC) tumors are associated with improved patient outcomes, yet the specific triggering antigens remain largely unknown. In this web...MAR 26, 2024 | 11:00 AM
Ever wonder what you’re missing in your data? The sheer complexity of today’s flow and mass cytometry datasets demands automated solutions. Machine learning plugins only provide...MAY 16, 2023 | 8:00 AM
The therapeutic use of chimeric antigen receptor T cells has achieved significant success in the treatment of B cells malignancies. Despite promising results in mouse tumor models, a similar...FEB 22, 2023 | 5:30 AM
Many current technologies used in drug discovery and preclinical development programmes typically involve multi-step operations, extensive hands-on time, and lengthy liquid handling processe...
OCT 05, 2022 | 10:30 AM
Learning Objectives: 1. Classify the obstacles to successful manufacturing of antigen-specific T-cells in immunotherapy. 2. Highlight the effects of CD45RA+ subsets in expansion of antigen-s...
Speaker:
Sandhya Sharma, PhD
Presented at: Cancer Research & Immuno-Oncology Week Virtual Event Series 2022
Sponsored By: Miltenyi Biotec
Sponsored By: Miltenyi Biotec
MAR 28, 2024 | 8:00 AM
B cell responses within pancreatic ductal adenocarcinoma (PDAC) tumors are associated with improved patient outcomes, yet the specific triggering antigens remain largely unknown. In this web...
MAR 26, 2024 | 11:00 AM
Ever wonder what you’re missing in your data? The sheer complexity of today’s flow and mass cytometry datasets demands automated solutions. Machine learning plugins only provide...
MAY 16, 2023 | 8:00 AM
The therapeutic use of chimeric antigen receptor T cells has achieved significant success in the treatment of B cells malignancies. Despite promising results in mouse tumor models, a similar...
FEB 22, 2023 | 5:30 AM
Many current technologies used in drug discovery and preclinical development programmes typically involve multi-step operations, extensive hands-on time, and lengthy liquid handling processe...
OCT 05, 2022 | 10:30 AM
Learning Objectives: 1. Classify the obstacles to successful manufacturing of antigen-specific T-cells in immunotherapy. 2. Highlight the effects of CD45RA+ subsets in expansion of antigen-s...
Speaker:
Sandhya Sharma, PhD
Presented at: Cancer Research & Immuno-Oncology Week Virtual Event Series 2022
Sponsored By: Miltenyi Biotec
Sponsored By: Miltenyi Biotec
JUL 21, 2022 | 8:00 AM
Date: December 09, 2022 Time: 11:00am (PST), 2:00pm (EST), 8:00pm (CEST) Flow cytometry is a trusted method to monitor T cell phenotype, plasticity, and functionality in basic research as we...
JUL 12, 2022 | 8:00 AM
Date: July 12, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) Dendritic cells (DCs) are a heterogeneous population of myeloid immune cells that act as peripheral sentinels specializin...
MAY 12, 2022 | 8:00 AM
Date: May 12, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Cell culture is key for efficient and reliable T cell workflows, be it activation/ and expansion, T helper cell polarizati...
MAR 24, 2022 | 8:00 AM
Date: March 24, 2021 Time: 08:00am (PDT), 11:00pm (EDT) Simply enough, we want to treat our cells well. Afterall, we want them to tell us their stories in basic research or work for us in th...
-
MAR 20, 2024 | 8:30 PM PDT
The premier event in NGS education is now available on demand. Since 2020, OncomineWorld meetings have brought together thousands of scientists and professionals from around the world each y...SEP 12, 2023 | 8:00 AM PDT
Tandem Mass Tags (TMT) have revolutionized the field of mass spectrometry by enabling simultaneous identification and quantification of protein expression from multiple samples in a single L...JUL 26, 2023 | 8:00 AM PDT
GenScript is delighted to announce its 3rd Annual Virtual Summit on Gene and Cell Engineering. This gathering will feature leaders in the life sciences from academia, pharma, and biotech, le...MAR 30, 2023 | 12:00 AM PDT
Don’t miss the premier event in NGS education. Since 2020, OncomineWorld meetings have brought together thousands of scientists and professionals from around the world each year to adv...JAN 31, 2023 | 8:00 AM PST
Empowering Multiplexing Innovation Luminex’s xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology u...
MAR 20, 2024
| 8:30 PM PDT
The premier event in NGS education is now available on demand. Since 2020, OncomineWorld meetings have brought together thousands of scientists and professionals from around the world each y...
SEP 12, 2023
| 8:00 AM PDT
Tandem Mass Tags (TMT) have revolutionized the field of mass spectrometry by enabling simultaneous identification and quantification of protein expression from multiple samples in a single L...
JUL 26, 2023
| 8:00 AM PDT
GenScript is delighted to announce its 3rd Annual Virtual Summit on Gene and Cell Engineering. This gathering will feature leaders in the life sciences from academia, pharma, and biotech, le...
MAR 30, 2023
| 12:00 AM PDT
Don’t miss the premier event in NGS education. Since 2020, OncomineWorld meetings have brought together thousands of scientists and professionals from around the world each year to adv...
JAN 31, 2023
| 8:00 AM PST
Empowering Multiplexing Innovation Luminex’s xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology u...
NOV 02, 2022
| 5:30 AM PDT
Labroots invites you to the 5th Annual Event in the CRISPR Virtual Event Series! This event will continue the conversation on the abilities of CRISPR-based editing, and much more....
OCT 19, 2022
| 5:30 AM PDT
Labroots announces the 2022 Coronavirus Virtual Event Series. A novel coronavirus emerged in China in 2019; it has since been dubbed COVID-19....
OCT 04, 2022
| 5:30 AM PDT
Labroots to host the 10th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Event Series! This two day event will take place on October 4-6, 2022....
SEP 21, 2022
| 5:30 AM PDT
Labroots to host the 6th Annual Event in the Cell Biology Virtual Event Series, providing an opportunity to discuss recent discoveries in biological research and more....